About this trial
This implementation study will examine the best ways to refer heavy smokers to information about lung cancer screening.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
QUITLINE CALL CENTER STAFF
Staff member of a quitline
Aged 18 years and above
CALLERS (SMOKERS WHO CONTACT THE QUITLINE ABOUT SMOKING CESSATION SERVICES) INCLUSION CRITERIA
Disqualifiers
CALLERS (SMOKERS WHO CONTACT THE QUITLINE ABOUT SMOKING CESSATION SERVICES) EXCLUSION CRITERIA
History of lung cancer by self-report
Trial design
Sequential
Treatments tested in this trial
Educational Intervention
Other interventionUndergo training consisting of a 60-minute educational session
Educational Intervention
Other interventionReceive lung cancer screening educational materials
Questionnaire Administration
Other interventionComplete questionnaire
Survey Administration
Other interventionAncillary studies
Treatment groups
Trial outcomes
Primary outcomes
Content from communications (email, phone, monthly calls)
Will be content analyzed using Atlas.ti qualitative software according to the adaptation framework from Stirman and colleagues. Will identify 1) who made the modification; 2) what was modified (i.e., content, context, training and evaluation); 3) for whom the modification was made (e.g., individual counselor); 4) context of the modification (e.g., format, setting, personnel, population); and 5) what was the nature of the modification (e.g., adding elements). Will also code for facilitators and barriers that are consistent with the constructs from CFIR. All textual data will be double coded and discussed by the researchers.
Healthcare sector perspective
As needed, will use a process-flow analysis to identify all resources utilized at each of the step of the program.
Reach
The analysis of the data from the logs and surveys will include examining the means, medians, standard deviations, and ranges overall and by state quitline for Reach
Overall lung cancer screening rate
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
M.D. Anderson Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator